Alexza ( ALXA) has spent the past month and a half analyzing the data ... Although meeting with the FDA could result in a positive development for the stock, the soonest we see a possible re-file on AZ-004 would be May / June 2011.
The shares of Alexza Pharmaceuticals, Inc (NASDAQ:ALXA) rose more than 23% to $2.80 per share after announcing the Grupo Ferrer Internacional, S.A. agreed to acquire 2 million of its common stock for $4.00 per share.
Alexza Pharmaceuticals (ALXA): Piper Jaffray juices its rating to Overweight from ... sending it up nicely before this morning's opening bell. (See also: New Stock Coverage: Six Flags Is a Fine Place to Park Your Money and Stock
NEW YORK, NY / ACCESSWIRE / May 13, 2016 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Alexza Pharmaceuticals, Inc. (NASDAQ: ALXA) stock
Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA), or the Company, today announced that it has priced its previously …
After I wrote about Nanocap a couple of days ago a reader was so kind to point me in the direction of Alexza Pharmaceuticals (NASDAQ:ALXA): another nano cap company ... $22.6 million or $0.90/share. With the stock
In this interview with The Life Sciences Report, Scott Henry of ROTH Capital Markets touts the value of “sound business models” in the specialty pharma space, and names six companies with interesting prospects and/or stock-moving …
ALXA shares recently were down about 3.3% at $2.07 apiece after turning lower soon after the opening bell and falling …
The company's stock closed at $1.21, down 8.33 percent. The Mountain View-based pharmaceutical company (NASDAQ:ALXA) reported revenue of $1.3 million compared to no revenue in the second quarter of 2010. The 2011 …
Alexza Pharmaceuticals Inc. (NASDAQ: ALXA) is trading at $4.52 ... gaining 0.64 or (8.84%) 11:38AM EDT. The stock has a morning high of $8.50 on volume of over 2. 1 Million shares. InvestorIdeas.com is a leader in investor stock